Photo of Patrick O'Connor
R Massachusetts Senate · District First Plymouth and Norfolk On the 2026 ballot

Sen. Patrick O'Connor

Compare
Total votes
1,653
all sessions
Attendance
100%
3 missed
Near the chamber average
With party
94%
of cast votes
Lower than 95% of chamber peers
Bipartisan score
3%
crosses aisle rarely
Higher than 92% of chamber peers
Sponsored
3,125
bills & resolutions
Higher than 82% of chamber peers
Committees
9
assignments
3,125 bills and resolutions

Sponsored bills

Total
3,125
Primary
644
Co-sponsor
2,481
This page
3,125
matching current filters
Co-sponsor S 1201
Passed · Massachusetts Senate · Co-sponsor
An Act relative to paid pregnancy loss leave

Maddy summaryThis bill establishes a new paid leave policy in Massachusetts that allows employees to take up to 10 days of paid time off each calendar year for pregnancy loss or related fertility issues. The leave is intended for individuals experiencing miscarriage, failed assisted reproductive procedures, unsuccessful adoptions, failed surrogacy arrangements, or other fertility-related diagnoses, as well as for those caring for a spouse or domestic partner facing these circumstances. Employers must pay employees their regular rate of pay and maintain their benefits during this time, though the bill exempts companies that already offer sufficient leave under similar conditions. The legislation also requires the state labor department to track the percentage of claims made for this specific type of leave and prohibits employers from forcing employees to find replacements while on leave.

Passed Nov 22, 2023 1 co-sponsor
Co-sponsor S 2492
Passed · Massachusetts Senate · Co-sponsor
An Act relative to pharmaceutical access, costs and transparency

Senate, October 30, 2023 -- The committee on Health Care Financing, to whom was referred the petitions (accompanied by bill, Senate, No. 732) of John J. Cronin for legislation to promote comprehensive transparency in the pharmaceutical industry; (accompanied by bill, Senate, No. 749) of Cindy F. Friedman, Rebecca L. Rausch, Susannah M. Whipps, Joanne M. Comerford and other members of the General Court for legislation relative to pharmaceutical access, costs and transparency; (accompanied by bill, Senate, No. 767) of Jason M. Lewis for legislation to define modest meals and refreshments in prescriber education settings; (accompanied by bill, Senate, No. 778) of Paul W. Mark for legislation to bring down the cost of prescription drugs; (accompanied by bill, Senate, No. 783) of Mark C. Montigny and Michael J. Barrett for legislation to promote transparency and prevent price gouging of pharmaceutical drug prices; (accompanied by bill, Senate, No. 784) of Mark C. Montigny for legislation relative to coverage for chronic illness; (accompanied by bill, Senate, No. 797) of Jacob R. Oliveira for legislation to bring down the cost of prescription drugs; (accompanied by bill, House, No. 619) of Nicholas A. Boldyga relative to establishing a prescription drug rebate program for seniors; (accompanied by bill, House, No. 1176) of Edward F. Coppinger and others relative to promoting comprehensive transparency in the pharmaceutical industry; (accompanied by bill, House, No. 1201) of Kate Hogan relative to the pricing of prescription drugs; (accompanied by bill, House, No. 1205) of Bradley H. Jones, Jr., and others that the Health Policy Commission and health insurers create listings of certain high cost prescription drugs and that the Attorney General require drug manufacturers to provide information to justify increases in costs; (accompanied by bill, House, No. 1206) of Bradley H. Jones, Jr., and others for an investigation by a special commission (including members of the General Court) relative to contracts between the MassHealth program and pharmaceutical benefit managers; (accompanied by bill, House, No. 1215) of John J. Lawn, Jr., and others relative to pharmacy benefit managers; (accompanied by bill, House, No. 1246) of William M. Straus relative to drug prices paid by carriers; and (accompanied by bill, House, No. 1247) of Alyson M. Sullivan-Almeida, Michael J. Soter and David F. DeCoste relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth, reports the accompanying bill (Senate, No. 2492).

Passed Nov 15, 2023 1 co-sponsor
Primary S 1900
Passed · Massachusetts Senate · Lead sponsor
An Act increasing the property tax exemption for disabled veterans

Maddy summaryThis bill increases the property tax exemption for disabled veterans in Massachusetts from $400 to $1,000. The change directly affects veterans with disabilities who own property in the state by reducing their annual property tax liability. The legislation achieves this by amending Section 5 of Chapter 59 in the state's General Laws to update the exemption amount.

Passed Nov 6, 2023 0 co-sponsors
Co-sponsor S 1882
Passed · Massachusetts Senate · Co-sponsor
An Act granting property tax exemptions to disabled veterans

Maddy summaryThis bill grants property tax exemptions to disabled veterans in Massachusetts who have a service-connected disability rating of 100 percent from the U.S. Department of Veterans Affairs. To qualify, the veteran must be at least 65 years old, a legal resident of the state, and have served under honorable conditions, while the property must be their primary residence. The exemption covers a percentage of the home's value equal to the veteran's disability rating, with the state covering the resulting tax loss by reimbursing local municipalities. Additionally, the benefit extends to the surviving spouse if they continue to own and occupy the home after the veteran passes away.

Passed Nov 6, 2023 1 co-sponsor
Co-sponsor S 756
Passed · Massachusetts Senate · Co-sponsor
An Act preserving special needs trusts for disabled seniors

Maddy summaryThis bill amends Massachusetts law to clarify how assets transferred into special needs trusts by seniors aged 65 or older are treated for Medicaid eligibility purposes. Specifically, it instructs the state to count these transfers as a disposal of resources at fair market value, meaning the value of the assets used to fund the trust will be considered available to the individual. This change directly affects disabled seniors and their families who rely on special needs trusts to maintain eligibility for government health benefits while preserving assets for their care. The provision ensures that the state can accurately assess an individual's financial resources when determining their need for assistance under the program.

Passed Oct 30, 2023 1 co-sponsor
Co-sponsor S 2003
Passed · Massachusetts Senate · Co-sponsor
An Act making October 25th Dwarfism Awareness Day in the Commonwealth

Maddy summaryThis bill designates October 25th as Dwarfism Awareness Day in Massachusetts. It requires the governor to issue an annual proclamation for the date and encourages the public to observe it appropriately. The law directly impacts state officials by mandating the issuance of this yearly statement. No new funding or operational changes are included in the measure.

Passed Oct 30, 2023 1 co-sponsor
Co-sponsor S 749
Passed · Massachusetts Senate · Co-sponsor
An Act relative to pharmaceutical access, costs and transparency

Maddy summaryThis bill establishes a new drug access program in Massachusetts to improve coverage for specific high-value medications used to treat chronic conditions like diabetes, asthma, and heart disease. It mandates that the state secretary of health and human services identify one generic and one brand-name drug for each of these conditions based on clinical evidence and cost-effectiveness, while explicitly designating insulin as the covered diabetes treatment. The program requires health plans to cover these selected drugs without requiring prior authorization or step therapy, aiming to reduce costs and improve patient adherence. Additionally, the legislation sets up a requirement to evaluate the program's impact on treatment adherence and healthcare costs every two years.

Passed Oct 30, 2023 1 co-sponsor
Showing 1,081 to 1,090 of 3,125 bills